News & Updates

September 14, 2018 | Content Update

The DAIDS RSC Regulatory Support Center (RSC) Website has been your go-to place for information on regulatory aspects of DAIDS clinical trial operations for over 10 years.

March 26, 2018 | Content Update

The updated Financial Disclosure Form for HPTN is now available on the DAIDS Financial Disclosure Forms page.

January 3, 2018 | Content Update

The “DAIDS Therapeutic Research Program Guidance for the Development of Protocol Procedures to Address Reproductive Risk” is now available on the Protocol Templates page.

December 12, 2017 | Content Update

The updated version of the “DAIDS Protocol Specific Informed Consent Template – General Use” is now available on the Protocol Templates page.

December 7, 2017 | Content Update

Updated versions of the “Lists of ​protocols ​having CRF/pharmacy records ​that will NOT be stored by DAIDS” are now available on the CRF Management page.

September 11, 2017 | Content Update

New pages for clinical research sites on Informed Consent Process Information and Delegation Logs are now available.

August 7, 2017 | Broadcast Memo

This course is required for all new reporters and submitters who do not have DAIDS Adverse Experience Reporting System (DAERS) access at the time this new Safety eLearning course is launched. Reporters and submitters with current DAERS access at the time of this launch will be not be required to take this course.

July 10, 2017 | Content Update

A corrected version of the DAIDS Adverse Event Grading Table is now available on the Safety Grading Tables page.

May 24, 2017 | Broadcast Memo

This course is required for all new reporters and submitters who do not have DAIDS Adverse Experience Reporting System (DAERS) access at the time this new Safety eLearning course is launched.

December 15, 2015 | Broadcast Memo

The DAIDS RSC is proud to work closely with other DAIDS Collaborators in support of the DAIDS mission. The Office of HIV/AIDS Network Coordination (HANC) is a valuable resource for DAIDS Clinical Trial Networks and Site Personnel.

November 20, 2015 | Broadcast Memo

All clinical research sites (CRSs) must have access to DAERS before a study begins to report expedited adverse events (EAEs) to DAIDS. Each CRS must have at least two (2) staff who, among themselves, have a combination of DAERS “reporter” and “submitter” roles.